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CHA~TER I 
HISTORICAL 
Vitamin A ,and Related Compounds 
The existence of an essential nutritional factor, 
later to be called vitamin A, was assumed without proof, 
and its physiological effects were described long before 
the isolation of the vitamin itself and the determination 
of its chemical structure. Dietary blindness, a disease 
recognized in ancient Egypt, was· shown in Denmark during 
World War I to be a symptom of vitamin A dificiency. 1 The 
Egyptians have recognized improvement from the effects of 
night blindness after ingestion of liver, an organ that 
stores vitamin A. 2 
Early attempts were made to isolate and identify 
vitamin A from a milk, butter, and egg yolk. 2 In 1920, 
two scientists, Drummond and Takahashi, independently were 
able to succeed in partial purification of vitamin A from 
from fish oil. 2 ' 3 However it was not until 1931 when 
Karrer and associates were able to determine the structure 
of (1) using a highly purified vitamin A from shark liver 
oil. 4 Karrer and co-workers were also able to prepare 
retinal esters, such as retinyl acetate, from the same 
1 
extracts of the shark.liver oil. 
OH 
'.CHO 
Synthetic Methods 
The first industrial synthesis of retinoids were 
carried out by Isler and associates around 1947. 5 The 
most economically important processes today are those of 
Hoffmann-La Roche and BASF. At Hoffmann-La Roche, Isler 
2 
and associates developed the first industrial synthesis of 
retinal (l) based on a reaction sequence they had used in 
1947 to synthesize crystalline (l). The last C-C bond-
forming step was a Grignard reaction between the c14 alde-
hyde (!) and the c6 acetylene compound (2) to give the 
carbinol (~),which was converted to retinyl acetate (l). 2 
3 
CHO 
~ OH 
! oo·· 
., 
OAc 
7 
After the discovery of the Wittig reaction in 1953, 
Pommer and associates applied the Wittig reaction to the 
synthesis of retinoids. This work culminated in a novel 
industrial retinal synthesis at BASF laboratories in 
Ludwigshafen, Germany, central to which is the linking of 
the c15 phosphonium salt (~) to $-formylcrotyl acetate 
(~) to give a mixture of 11-cis-retinyl acetate (.!..Q_) 
ahd all-trans retinyl acetate (l). 2 
7 
~ ~Pcc6H5i3e; 
8 
l 
+ 10 
OHC~OAc 
ft. 
OAc' 
The Wittig .reaction was not only economically 
advantageous for the synthesis of vitamin A, it was also 
employed in the synthesis of different carotenoids, com-
pounds with aromas and flavors, juvenile hormones, and even 
prostaglandins. 216 Some advantages of the Wittig reaction 
are: 1) the reaction occurs in high~yield; 2) high 
selectivity is possible; 3) there is no limit to the number 
of carbon atoms. Its major disadvantages are that the 
triphenylphosphine oxide by-product is sometimes difficult 
7 to separate and stereoisomeric mixtures are produced. 
Chemical Properties 
Retinol (l) is chemically unstable and readily 
undergoes decomposition by the action of oxygen and heat. 
5 
In the presence of light, retinal (1) undergoes cis-trans 
isomerization, a fundamental reaction in the chemistry of 
vision. It is acid sensitive, but in the presence of a 
mild oxidizing agent such as manganese dioxide, it produces 
retinal (2) without cis-trans isomerization. 
Retinal (2) is the aldehyde analog of (ll and the 
biosynthetic intermediate in the conversion of carotene to 
(1) in the intestinal mucosa of animals. 8 In 1933, 
Wald discovered that the "visual purple or rhodopsin" in 
the eye is a complex of a protein opsin and the polyene 
retinene, later identified as vitamin A aldehyde or retinal 
( 2) • 9 
Retinoic acid (l), like land~, is also 
susceptible to oxidation. In the presence of light, 
iodine, acid, and heat, l, like 1 and ~' undergoes 
cis-trans isomerization. 10 Retinal (2) can be reduced 
to retinal with lithium aluminum hydride without isomeriza-
tion of any double bond. 9 
Retinoids 
About 50% of the total cancer deaths in the United 
States are due to malignancies in epithelial tissues, 
including lung, pancreas, colon, bladder, breast, and 
9 
ovary. Cytotoxic chemotherapy, surgery, and radiation 
are some of the techniques being employed to combat these 
malignancies in their acute stages. Recently, it has been 
suggested that the better approach to combat cancer would 
be to treat the disease during its period of progression, 
after the tissue has been exposed to a carcinogenic insult 
but before the lesion produced has become invasive. 11 
6 
One possible approach to th~s problem is the use of vitamin 
A and compounds related to it called retinoids. 
Retinoid is a general term that includes both the 
naturally occurring compounds with vitamin A activity and 
synthetic congeners with or without the biological activity 
of retinal (1). Retinoid compounds may include 
metabolites, oxidation products such as retinal (2) and 
retinoic acid (l), reduction products, or derivatives 
thereof, either synthetically or naturally derived, which 
may or may not exhibit the vario~s physiological activities 
attributed to retinal (1). 9 During the IUPAC-IUC Joint 
Commission on Biological Nomenclature (1982), it was 
recommended that the term vitamin A should be used as a 
general descriptor for retinoids exhibiting qualitatively 
the biological activity of l_. This term should be used 
in derived .terms such as vitamin A deficiency, and vitamin 
. 2 A antagonist. 
Activity of Retinoids 
Retinoids are involved in the maintenance of a normal 
epithelium in such tissues as the skin, lting, colon, 
urinary bladder, and mammary gland. The beneficial effects 
safety of retinoids must be proven first in test animals 
before investigations in man can take place. Biological 
7 
methods of analysis are important tools for both the 
practical development qf new retinoids and for the· analysis 
of their mechanisms of action since they measure highly 
specific cellular responses. 
Bioassay methodology is of special importance in two 
major areas of retinoid research: 1) To screen for new 
retinoids that might be useful for prevention or treatment 
of numerous diseases. Bioassay methodology can inform the 
synthetic organic chemist that two retinoids which differ 
by as little as cis-trans configuration around a double 
bond or the location of a carboxyl group (ortho-, meta-, 
or para-) on a benzene ring, could have surprisingly 
different functional activity. 2) To begin to explore the 
problem of the cellular mechanism of action of retinoids, 
which still remains unsolved after more than 50 years since 
the original discovery of their biological activity. 
Bioassay systems make it possible to analyze how chemical 
structures are transduced into biological function. 
-
Knowledge of structure-function relationship in various 
biological test systems by itself can provide important 
information with respect to the mechanism of action. 9 
In vivo methods useful for biological analysis and 
assay of retinoids include mouse papilloma test, the 
2 9 
ornithine decarboxylase assay, and others. ' In vivo 
assay methods are of particular importance for measuring 
the biological actiyity of various metabolites of l and l' 
for screening of new retinoids for potential usefullness as 
8 
pharmacological agents, and for predicting the clinical 
'l't f . 'd 219 uti i y o retinoi s. Some of the in 'vivo methods 
and findings pertaining to it are described below. 
Papilloma Test 
This method, developed and extensively used for drug 
screening, measures the ability of retinoids to cause 
regression of papillomas and gives an estimate of the in 
vivo toxicology of a retinoid. In the standard test 
system, the initiator 7,12-dimethylbenz(a)anthracene, DMBA, 
is applied twice at a 14-day interval to shaved dorsal skin 
of mice. A promoter, croton oil, is applied after 21 days 
at twice per week, and this tre~~ment is continued for 3-8 
months until animals develop multiple papillomas. At this 
point treatment with retinoids is begun either 
2 intraperitoneally or orally~ 
Ornithine Decarboxylase (ODC) Activity 
The induction of ornithine d8carboxylase is one of the 
essential events in teh process of carcinogenesis based on 
the study of the biochemical mechanism of tumor formation 
. h . k' 12 in t e s in. Both natural and synthetic retinoids have 
been tested in this in vivo/in vitro system. 13 The 
ODC assay is a highly sensitive in vivo assay that gives 
significant responses to a single application of less 
than a nanomole (300 ng) of 3. It is the simplest in 
vivo test because no special colony of animals is required 
9 
and the enzyme assay is not especially difficult. ODC 
studies have indicated that TPA (l..l), 12-0-tetradecanoyl-
phorbol-13-acetate, the active principle of croton oil, is 
a potent inducer of the enzyme ornithine decarboxylase 
(ODC), and that retinoids can block this enzyme induction. 
The ODC assay is performed as follows. The retinoid and 
TPA are each dissolved in acetone and applied to the shaved 
dorsal skin of mice. The mice are pretreated with an 
appropriate dose of retinoid one hour before the applica-
tion of 17 nmol of TPA (11). The mice are sacrificed 4.5 
hours after dosing with TPA, which is the time of maximum 
ODC induction in the skin. Epidermal preparations, sepa-
rated by brief heat treatment, from three or four mice are 
homogenized in neutral phosphate buffer containing 0.1 mM 
pyridoxal phosphate and 0.1 mM EDTA and centrifuged to get 
2 14 
a clear extract. ' The ODC activity of this extract is 
determined by measuring the release of labeled co2 from 
( 14c)-orni'thi'ne. 15 D t · d · · 13 · t' · e ermine in vivo, -cis-re inoic 
acid (..!.1_) has activity that is comparable to its all-
trans isomer (3) when it is applied directly to the 
skin. 13-cis-Retinoic acid (12) is the most useful of 
all retinoids, to date, for systemic administration of a 
variety of human skin diseases. Amide derivatives are 
inactive in this test. 2 
11 
In vitro methods have recently been evaluated for 
the determination of the biological activity of retinoids. 
Advantages 'of in vitro methods are that they require 
smaller quantities of the compound for testing, and data 
can be obtained in a relatively short period of time. In 
vitro methods include a hamster tracheal organ culture, 
HL-60 leukemia cell, and others. Some of the methods and 
findings are described below. 2 
Hamster Tracheal Organ Culture Assay 
The hamster tracheal organ culture assay is a highly 
10 
sensitive, precise, and reproducible bioassay method which 
measures a physiological induction of differentiation in a 
serum free system that has been essentially depleted of 
d . "d 9,14 en ogenous retinoi . This method has been utilized 
in the prevention of epithelial cancer _by retinoids. The 
presence of dark purple keratohyaline granules and bright 
pink· keratin are the histological end-points measured. 
Analogs are scored as -"inactive" if both keratin and 
keratohyaline granules are seen and "active'' if neither 
1°4 keratine or keratohyaline granules are seen. 
The tracheal organ culture assay is an excellent 
method to study the biological and chemical properties of 
retinoids and particularly ~or measuring the structure-
11 
activity relationships. A complete dose-response curve can 
be obtained in a tracheal organ culture with as little as 
1-10· ng sample of a highly active retinoid. Some 
disadvantages of this bioassay method are that it requires 
special animal care, and the method is definitely more 
expensive than other in vitro methods. 14 , 16 
Human Promyelocytic Leukemia 
Cell Line HL-60 Assay 
HL-60 cells can be ~nduced to differentiate terminally 
to morphologically mature granulocytes by in vitro treatment 
with a wide variety of compounds, including sodium 
butyrate, hypoxanthine, aimethylsulfoxide, dimethylformamide, 
d . . 2 an actinomycin D. The capacity of HL-60 cells to 
reduce nitroblue tetrazolium is the basis for the bioassay 
of retinoids in a serum free medium. 
Retinoids are added to the HL-60 cells at the start of 
the assay. Ethanol is used as the vehicle. The HL-60 
cells are incubated for 4 or 5 days. Differentiation is 
measured by nitroblue tetrazolium (NBT) of cytopsin slide 
preparations. Results are expressed as percentage of NBT 
positive cells. Approximately 4-8% of the cells will 
differentiate spontaneously in the absence of retinoid. 2 
Breitman reported that physiological amounts of 
retinoic acid (3) would.cause induction of differentia-
tion in HL-60 cells, the levels of l that are required 
are one-thousandth to one-millionth of those of the other 
inducers. Retinoic acid (3) at a concentration of 10- 9 
~ will induce approximately 20% of the HL-60 cells in a 
culture to differentiate. 14116 
Problems Associated With 
Natural Retinoids 
12 
The toxicity of retinoids is one of the major problems 
when considering retinoids in cancer prevention. Altera-
tions of the skin, hair loss, desquamation, and headache 
are among the symptoms observed in humans with excess 
vitamin A. Takahashi observed loss of hair, emaciation, 
paralysis of the hind legs, and death within several weeks 
to mice and rats given crude concentrate of vitamin A 
orally. 1117 Sporn and associates have indicated that the 
nature of the polar end of a homologous series of retinoids 
is an important determinant of their toxicity. 18 Toxicity 
can be diminished by the synthesis of analogs with less 
14 polar end groups. Thus carboxylic acid derivatives are 
more toxic than their ester or amide analogs. Alcohols are 
more toxic than their ether analogs. 14 
Another major concern is that retinoids may increase 
the carcinogenic effect of certain substances in selected 
systems. Experiments by Forbes in which hairless mice 
13 
received daily application of 0.01% or 0.001% retinoic acid 
(l} in methanol and were exposed to ultraviolet irradia-
tion resulted in marked enhancement of tumor formation. 
Under this condition, 3 enhanced utraviolet 
. . 14 tumorigenesis. 
Synthetic Retinoids 
As mentioned earlier, a major problem associated with 
natural retinoids is their inherent toxic properties. 2 
The use of both 3 and 7 in the chemoprevention of 
cancer is severely limited by their toxicity when adminis-
tered in pharmacological doses. 14 Thus, it is necessary 
to develop synthetic retinoids possessing pharmacological 
properties significantly different from those of natural 
retinoids so that toxicity is reduced while the preventive 
activity is retained. One interesting property of some new 
synthetic retinoids is their relatively high stability 
compared with the classic retinoids, although dilute solu-
tions of these compounds still undergo isomerization under 
the action of light to give a mixture containing cis and 
. 2 trans isomers. 
Synthetic retinoids have been synthesized and tested 
in various ways to determine their biological activity in 
terms of growth, differentiation, and antipromoting 
activities. In the papilloma test, a new synthetic 
retinoical benzoic acid derivative TTNPB (1..l, tetrahydro-
tetramethylnapthalenylpropenylbenzoic acid) and. its ethyl 
ester have been found to be more active than 3. 
COOH 
_, 
The synthetic analog that has been most extensively 
studied is the 13-cis isomer of retinoic acid (_!_l). 
Compared to 3, 13 has a lower toxicity in both mice and 
rats. 1 In 1982, two synthetic retinoids were introduced 
into the clinical practice of dermatology. In the United 
States, Accutane, whose active agent is 12, was approved 
... -· 
for the treatment of severe cystic acne. In Europe, 
etretinate (.!_i), marketed as Tigason, is in use either 
14 
alone or in combination with other agents for the treatment 
of psoriasis and related cutaneous disorders of 
k . . . 14 erat1n1zat1on. 
· 14 
The main objective of our research was to synthesize 
the new retinoid compound ~which, hopefully, would be 
more active than any natural retinoids but less toxic. We 
hoped that by changing the basic retinoid structure, a 
clinically useful com~ound could be synthesized that will 
concentrate in specific target tissues. 
10 15 
12 OOH 
3 ~ 
13 
2 
8 15 
15 
CHAPTER II 
RESULTS AND DISCUSSION 
Retinoids are rapidly oxidized or isomerized to 
altered products in the presence of light or oxidants. 
Because of their instability, all retinoid products were 
handled with extra caution. The oxa-retinoic acid (12.) 
after recrystallization from absolute ethanol was carefully 
dried, sealed under a nitrogen atmosphere and kept in a 
freezer at o0 c in an amber colored bottle. Considerable 
attention was paid during extraction. The separatory 
funnel was wrapped with an aluminum foil and most of the 
lights in the laboratory were turned off. The same 
precautions were observed during vacuum evaporation of the 
solvents used and during chromatographic analyses. 
Methyl 3-phenoxypropanoate (_1_2_) and 
19 2-Methyl-4-phenoxy-2-butanol (18) 
The ester (17) was prepared by boiling a solution of 
3-phenoxypropanoic acid (16) in methanol for 4 h with 
E-toluenesulfonic acid as the catalyst. Reaction times 
were varied from as much as 48 h to as short as 4 h. All 
esters were vacuum distilled before proceeding to the next 
reaction. Percent yields, after vacuum distillation, 
16 
SCHEME 1. Preparation of the 4,4-Dimethylchroman (19) 19 
·· CH30.H, _p_-TsOH 
hea.t, 4 h 
.CH3MgBr 
.. d,iE;~t~yl ether 
. r.~t.,. 4 h 
o~OH 
. . 
18 
19 
AlC1 3, CH3N02 
r.t.,6h 
17 
18 
varied from 80% to 88%. A reaction time of 4 h was found 
to be the most suitable with yields around 88% after vacuum 
distillation. A Grignard reaction was employed to convert 
lI_ to the tertiary alcohol (~). The tertiary alcohol 
(]J!_) was prepared by adding methylmagnesium bromide in 
THF to an ether solution of 17 in a nitrogen atmosphere. 
Yields· varied from as low as 30%, using smaller amounts of 
reagents but maintaining the same molar ratio, to as much 
as 80%, after vacuum distillation, using scaled up 
quantities. Ammonium chloride, a mild acid, was used as 
the quenching agent. Precautions were observed after vacuum 
distillation of ~, a tert~ary alcohol which could 
dehydrate. Both 17 and 18 were found to be colorless 
liquids, stable for at least twelve months. Infrared, H-1 
NMR, and C-13 NMR spectra were taken for all compounds. 
4,4-Dimethylchroman (.!2_) and 6-Ethanoyl 
4,4-Dimethylchroman (20) 19 
The dimethylchroman (.!2_) was prepared by adding a 
solution of 18 in nitromethane to a solution of aluminum 
chloride in nitromethane. The addition of the first few 
drops of 18 to the aluminum chloride solution turned the 
solution cloudy. Upon the addition of all of the solution 
of 18 to the aluminum chloride solution, the color of the 
mixture was blood red. The reaction was followed by thin 
layer chromatography. After the third hour, a small amount 
of the starting material 18 was observed. During the 
19 
fourth hour of the reaction only one spot, corresponding to 
compound .!2. was ,observed. The acetyldichroman (~), a 
yellowish liquid, was prepared by adding a nitromethane 
solution of anhydrous aluminµ~ chloride to a solution of 
acetyl chloride and 19 in nitromethane. Different 
reaction times were tried, 6, 24, and 48 h, and yields 
obtained after vacuum distillation were low. Yields of 13, 
30, 40, 44, and 48% were obtained. Generally, increased 
reaction time led to increase yield. The molar ratio of 
aluminum chloride: acetyl chloride: 1:.2_ was maintained 
at 1: 1: 1 in order to prevent further acylation at other 
sites. The reactions were conducted at room temperature 
only and the starting material 1:..2._, whose boiling point 
under vacuum is lower than ~, was recovered during 
vacuum distillation of 20. Generally, about a third of 
the original weight of the starting material 19 was 
recovered, though the percent yield calculations were based 
on the original amount of 19 used and not on the amount 
of 20 that reacted. 
Formation of the Phosphonium Salt (22) 
The alcohol (_~]J was prepared by adding a solution 
of vinyl magnesium bromide to a stirred solution of 20 in 
anhydrous ether. The product 21 was never purified and 
was converted to the phosphonium salt (22) right away. 
In one instance, 21 was kept in the refrigerator 
Scheme 2: Preparation of the Phosphoniurn salt (22) 
1.9 
20 
21 
. ·22. 
CH3COC1, A1Cl 3 
r.t.,6h 
0 
~ 
CH2=CHMgBr 
diethyl ether, N2 
PPh3.HBr 
diethyl ether 
20 
overnight and the crude, viscous, brown solution.of 21 
yielded clear colorless crystals on the sides of the 
container which quickly liquif ied upon exposure to room 
temper.ature. The phosphonium salt (~), was obtained from 
the reaction of equal number of moles of the crude 21 and 
triphenylphosphine hydrobromide. 
Oxa-Retinoic Acid (15) 
The Wittig reaction was used to prepare the retinoid 
ester (24). The reaction of 22 with ethyl 3-formyl-2-
butenoate (~) plus a base, ~-butyllithium or sodium 
ethoxide, gave crude 24. Percent yields varied from 
48-89%. Both H-1 and C-13 nmr of the crude retinoid ester 
~ indicated the presence of triphenylphosphine oxide. 
Thin layer chromatography of the crude 24 was performed 
using petroleum ether:ethyl acetate (98:2) as the mobile 
phase. Several spots were observed. Flash chromatography 
of the retinoid ester (24) was done to get rid of the 
triphenylphosphine oxide by product. C-13 and H-1 nmr of 
the chromatographed ~ indicated a mixture of isomers. 
The oxa-retinoid ester (~) was hydrolyzed to the oxa-
retinoic acid (1:2_), as discussed in the experimental 
section, and 15 was recrystallized from absolute ethanol. 
H-1 and C-13 nmr revealed a single isome~ of 15. 
Repeated recrystallization of 15 from absolute ethanol 
yielded the same all-trans isomer. The oxa-retinoic 
acid (}2), was obtained as yellow crystals and identified 
21 
SCHEME 3. Preparation of the Oxa-retinoic Acid (12_) 
3 
2 
8 
1. n-Buli or NaOEt 
2. 
. 23 
24 
KOH, EtOH, H20 
50°C, 4 h. 
10 15 
OOH 
22 
23 
by its IR, UV, H-1 NMR, and C-13 NMR. The melting point, 
the yellow color, and the spectra did not change with 
further recrystallization. Hydrolysis of the ethyl oxa-
retinoid ester (24) to the oxa-retinoic acid (~), as 
described in the experimental part, was carried out care-
fully under a nitrogen atmosphere and in a dark environment 
to prevent the oxidation of the· oxa-retinoic acid (15). In 
our experiments, both chloroform and methylene chloride were 
used as the extracting solvents. The solution wa~ first 
acidified with 6 M HCL before extraction with either 
chloroform or methylene chloride. Retinoids with a free 
carboxylic acid moiety show a selective extraction into the 
organic phase, depending on the pH of the extraction 
mixture. 2 At pH above 7, the retinoid remains in the 
aqueous layer, while acidification of the mixture allows 
the retinoid to be extracted into the organic phase. Iso-
merization during extraction has also been demonstrated. 2 
Zile has observed an 11% isomerization of 3 to 12 after 
extraction of bile with 1-butanol. 2 Goodman has reported 
the isomerization of 12 to 3 within 5 minutes after 
exposure to standard flourescent light with a 75% (_!_~_): 
25% (l) steady state being reached in 1-2 h. 2 
Polymeric Wittig Olefination 
Polymeric reagents are polymers that carry functional_ 
20 groups. In recent years there has been a great interest 
in polymer-supported reactions. Wittig reactions using 
24 
various alkyltriphenylphosphonium halides and aldehydes have 
21 been carried out successfully. 
Polymeric-supported Wittig reactions have the 
advantage of simplified work-up procedures, in particular 
the easy removal of the polymer-bound phosphine oxide by-
. 19 product. Another advantage is that the formation of 
by-products can be suppressed in some cases since 
intermediates, which are now more easily separated, can be 
7 
removed. Ethyl retinoate (ethyl ester of l) have ~een 
prepared using polymer supported Wittig reagents, in 55% 
yield, without the need of chromatography, extraction, or 
crystallization to remove the usual triphenylphosphine 
22 
oxide by-product. 
Polystyryldipheny'iphosphine (ll) and Poly-
styryldiphenylphosphonium bromide (28) 23 
A 2% cross-linked polymer was used because there is a 
faster transport of reag.ents in and out of the polymer 
matrices. Highly cross-linked polymers have been reported 
to give poor· yields, especially if the reactant and product 
molecules are large and therefore transport in and out of 
the polymer matrices is slow and difficult. 
A 2% cross-linked bromopolystyrene (~) was treated 
with ~-butyllithium in anhydrous toluene to give the 
lithiated product l§_ under an argon atmosphere. 
The product l§_ was never isolated, but proof of its 
formation was based on the colors observed. The product 
SCHEME 4. Preparation ·of the Polystyryldiphenylphos-
phonium bromide (28) 
n-Buli 
-15oC--+ r.t.., 24 h 
Br 
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26 is brown in toluene and is colored red when THF is 
used as the solvent. Both colors were observed when the 
product was either suspended or washed with either toluene 
or THF. Upon washing the product ~' the solvent was 
changed to THF. Chlorodiphenylphosphine was slowly added 
to form polystryryldiphenylphosphine (~). The product 27 
was converted right away to ~ by passing hydrogen 
bromide gas for 15 min to a suspension of 27 in dry 
benzene. Indication of the formation of 28 was confirmed 
by P-31 nmr analysis. 
Polymer Supported Wittig Reactions 
The reaction between the al~ohol (~) and the poly-
styryldiphenylphosphine hydrobromide (~) was carried 
out in dimethylformamide with a yield of only 21%. One 
possible factor for the very low yield of this reaction is 
the size of 21. It is possible that due to its 
relatively large size, ~ may not have reached the 
reactive sites in the polymer matrices. The solyent used, 
DMF, maybe another factor for the relatively poor yield of 
this reaction. It may not have swelled the polymer 
properly. Improper stirring methods could be another 
27 
factor. Polymeric Wittig reactions were also done under a 
dark environment. It has been reported that yields of 
polymer-bound reagents were highest with a 2% cross-linked 
support. 22 Two different bases, sodium ethoxide and 
~-butyllithium were used. The reactions were run in 
anhydrous ether so that yield can be compared with non-
polymeric Wittig reactions. The yield obtained when using 
sodium ethoxide was used as the base was 85%. Yield using 
~-butyllithium was 65%. Yields using poolymeric reagents 
were comparable to the non-polymeric Wittig reactions (68% 
using ~-butyllithium and 89% using sodium ethoxide). The 
solvent used during polymeric Wittig reactions was ether, 
which is a relatively poor swelling solvent and thus could 
account for the slightly lower yields when compared to the 
non-polymeric reactions. The product .£!by the polymer 
route also· indicated a mixture of isomers by nmr and hplc 
analyses. Thin layer chromatography and infrared results 
are the same as those of non-polymeric Wittig reactions. 
Characterization of the Oxa-
retinoid ester (24) 
The oxa-retinoid ester (~) obtained from both 
polymeric and non-polymeric reactions indicated a mixture 
of isomers. Thin layer chromatography of the crude 24 in 
silica gel using ether: ethyl acetate (98:2) as the 
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solvent system indicated the presence of a number of spots. 
The major spot (Rf value=0.68), was observed as a clear 
yellow spot when viewed under a visible light and was 
colored purple when viewed under an ultraviolet light. 
Another spot was observed at an Rf value of 0.83. It was 
later identified, using nmr and infrared techniques, to be 
that of the starting aldehyde ester (23). The other 
starting material ~ and the triphenylphosphine oxide by-
product were also detected by thin layer chromatography. 
Rf values for both were between 0.00 and 0.10. 
Thin layer chromatograppy, using silica gel plate, of 
crude 24 in other solvent systems was also tried. An Rf 
value of 0.96 was observed for the oxa-retinoid ester when 
diethyl ether:ethyl acetate (98:2) was used as the solvent 
system. Using pure chloroform as the solvent, the Rf 
value was equal to approximately 0.87. In hexane:ethyl 
acetate (3:1), the Rf value observed was equal to 0.72. 
The retinoid estser (24) was easily observable since it 
appears as a yellow spot when observed by the unaid~d eye 
under a visible light. 
Further characterization of the crude 24 was done to 
learn more about it. High performance liquid 
chromatography was used to characterize 24. Several 
solvent system combinations were tried. Flow rates were 
varied and a refractive index detector was used at first. 
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A reverse phase column, made up of silica, was tried at 
first. In the ·reverse phase system, more polar compounds 
will elute first, and the system is not sensitive to the 
presence of water either in the sample or in the solvents. 
The result of the reverse phase hplc experiment is depicted 
in Figure 1. 
The starting aldehyde ester (23) is responsible for 
the small peaks at 2.75 to 4.59 minutes, and the triphenyl-
phosphine oxide by-product of the Wittig reaction appeared 
30 
Figure 1. Separation of crude oxa-retinoid ester (24) 
isomers by HPLC. Column: Whatman Partisil 
5-0DS-3; Solvent System: Methanol:0.01 M 
Ammonium Acetate (90:10); Detector: Waters 
R401 RI Detector 
at 3.79 minutes. The two isomers of l,!, which are 
probably the 12-cis l,! and the all-trans 24 came 
out at 10.58 and 11.28 minutes. 
all,;.trans·24 
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The fractions were collected in a dark room to prevent 
possible isomerization. H-1 and C-13 nmr of the fractions 
have never indicated a pure isomer. A possible explanati-0n 
for.this is isomerization during collection and extraction. 
The ultraviolet absorption of the collected fractions, from 
the HPLC experiments, were also determined. Absorption 
spectroscopy has been employed as an aid in the 
characterization of structure. For our oxa-retinoid ester 
(~), the first fraction exhibited a A = 348 nm in 
max 
methanol:0.01 M ammonium acetate (9:1). The second 
fraction had a ). = 356 nm. The mixture of the fractions 
"max 
exhibited a A = 350 nm. These results indicate that the 
max 
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first fraction is probably the 12-cis isomer of (~), since 
it has a more twisted double bond system and, therefore, 
will absorb at shorter wavelength. 
Normal phase HPLC was also tried to separate the 
geometric isomers of 24. Retinoids that differ by 
isomeric configurations of their side chain have been 
separated by this method. Hexane with minor amounts of a 
more polar organic modifier has been chosen almost 
universally as the eluting solvent. 2 
The fractions collected from the reversed-phase HPLC 
experiments were the one reinjected in the normal phase 
-
experiments. The detector was changed to ultraviolet set 
at 313 nm. Most retinoids normally absorbs around 354 nm. 
The solvent system chosen was hexane:diethyl ether (90:10) 
for several reasons including: 1) the separation of the 
peaks_is better, 2) the injection or run time is shorter, 
and 3) the solvent system chosen is easy to remove from the 
desired compounds. 
Injection of the first fraction collected from the 
reversed phase experiments indicated the presence of at 
least htree major peaks (Figure 2b). The first peak, at 
4.25 minutes, looked like a collection of several peaks. 
Two other peaks, 7.55 minutes and 8.59 minutes were 
observed. Both peaks were sharp and were probably the two 
major isomers of the oxa-retinoid ester (~). 
The fractions at 7.55 and 8.59 minutes were collected 
and reinjected again to verify their purity. Each of the 
. (a) . 1 . 5 0 · m LI m-i n 
Figure 2. Separation of oxa-retinoid ester (~) isomers 
by HPLC. Column: Whatman Partisil 5; 
Solvent System: Hexane:Diethyl Ether (90:10). 
Detector: Beckman Analytical UV Detector 
Model 153 at 313 nm. 
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collected fractions showed a single peak indicating that 
the fractions collected were pure. The samples were 
submitted for proton NMR, bu~ the amount collected was not 
sufficient to obtain a good spectrum and it was not 
possible to distinguish many of the peaks from background 
noise .. 
In the normal phase liquid chromatography, the solvent 
system used was quite non-polar. It is expected that the 
more non-polar compound will come out first. It was 
expected that the trans-isomer, which is less polar than 
the cis-isomer, would come out first. To verify this 
statement, the ultraviolet absor~tion spectra of each pure 
isolated fraction was obtained. The A of the first 
max 
fraction in hexane was 346 nm and the second one has a 
A = 335 nm. This supports our statement that the 
max 
first fraction is probably the all-trans isomer or the less 
polar isomer and the second fraction is probably the more 
twisted 12-cis isomer, which is expected to absorb at a 
shorter wavelength than the all-trans isomer of 24. 
The Biological Activity of the Oxa-
retinoic acid (1:2_) in the HL-60 
Leukemia Cell Bioassay 
Recently, the all-~E~ns-retinoic acid (l) was 
found to be the most potent inducer of the granulocytic 
differentiation of HL-60 cells. Our compound, the oxa-
retinoic acid (]:2) was submitted for the HL-60 assay, and 
the results of the assay are tabulated below. The results 
with a newly synthesized retinoid, a sulfur containing 
retinoid (lQ_), closely related to .!2_, are included for 
comparison. 
ED 50 , the median effective dose, is the amount of 
retinoid required in achieving a half-maximal response. 
The results of the HL-60 cell line bioassay indicate that 
TABLE I 
RESULTS OF THE HL-60 LEUKEMIA 
CELL BIOASSAY 
Retinoid 
Retinoic Acid (3) 
Oxa-retinoic Acid (15) 
Sulfur-retinoic Acid 
( l.Q_) 
41 nM 
200 nM 
72 nM 
15 is about five times less active than 3 and three 
times less active than l.Q_ in this bioassay. 
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In two differentiation assays, the HL-60 assay and the 
F9 assay (an assay similar to the HL-60 assay), the new 
synthetic retinoid 13 is a potent inducer of differentia-
tion. It had an ED 50 approximately 100-fold lower than 
l in the F9 assay and an ED50 three-fold higher than l 
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in the HL-60 assay. The substitution of an oxygen atom in 
the cyclohexyl ring of TTNPB (1.l_) appears to be responsible 
for this large decrease in activity. This is consistent 
with the findings of Breitman that 15 is much less active 
than 30. However, substitution of a sulfur atom in the 
cyclohexyl ring of TTNPB (13) results in a large decrease 
in activity in the tracheal organ culture assay and in the 
ability to bind to the cytoplasmic retinoic acid binding 
protein. 
Results have indicated that the most effective 
retinoid inducers of HL-60 differentiation process possess 
a carboxylic acid function at the terminal carbon. Substi-
tution at the C-15 position of retinoic acid 3 resulted 
in esse~tially a complete loss of activity. Thus, retinal 
(l),. retinal (~), and retinyl acetate (l), are all inactive 
in the HL-60 assay. 
Inhibition of Ornithine Decar-
boxylase Activity 
Our compound, the oxa-retinoic acid 15 was submitted 
and tested for its inhibition of the ODC activity. The 
results along with some newly synthesized retinoids are 
tabulated in Table II. 
Test 
TABLE II 
ORNITHINE DECARBOXYLASE ACTIVITY 
OF VARIOUS RETINOIDS 
System Dose in ODC 
nmol Activity 
Acetone-TPA UJJ 5.3 + 0.7 
-
trans-retinoic acid (l_) 34 1. 0 + 0.1 
Oxa-retinoic acid 34 0.95 + 0.06 
(12_) + TPA 11 
31 + TPA UJJ 34 1. 7 + 0.10 
32 + TPA UJJ 34 3.5 + 0.20 
33 + TPA (]JJ 34 1. 5 + 0.40 
37 
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COOH 
32 
-
The ODC activity was based on the nmole of carbon 
dioxide released per 60 minutes per milligram protein. 
During the experiments 34 nmol each of the retinoids were 
used. The retinoic acid (ll inhibited ODC activity by 
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81% while the new synthetic retinoid, the oxa-retinoic acid 
(_l_~), inhibited the ODC activity by 82%. The other 
compoupds tested were not quite as active as 15 and 3. 
The alcoholic compound (3f) inhibited the ODC activity by 
68% while its aldehydic analog (~) gave an inhibition of 
only 34%. A similarly related compound 33 with an ester 
functionality was quite active too. It gave a 72% 
inhibition of the ODC activity. The results of the ODC 
assay for _!2 indicates that this new retinoid is more 
active than 3. However, toxicity tests should be 
cond"ucted for the oxa-retinoic acid (_!2) in order to 
appraise its usefulness as a potential drug. A number of 
new synthetic retinoids have proven useful in the 
prevention of cancers of various organs without noticeable 
appearance of hypervitaminosis syndrome, a problem 
associated with natural retinoids. 
CHAPTER III 
EXPERIMENTAL SECTION 
General Information 
All reactions were run under a nitrogen or argon 
atmosphere. Evaporation of the solvent was performed on a 
rotary evaporator with .reduced pressure (water aspirator). 
The starting material, 3-phenoxypropanoic acid (99% pure), 
was purchased from Aldrich Chemical Company. Toluene, 
tetrahydrofuran, ~,~-dimethylformamide, and nitromethane 
were distilled and dried prior to use. Solvents such as 
methanol, ethanol, methylene chloride, acetonitrile, 
diethyl ether, acetone, hexane, pentane, ethyl acetate, 
petroleum ether (bp 45-60°C) and other chemicals such as 
anhydrous aluminum chloride, acetyl chloride, 
methylmagnesium bromide, vinylmag~esium bromide, and 
triphenylphosphine were used without further purification. 
Sodium ethoxide was prepared by dissolving a weighed amount 
of freshly cut sodium in a measured volume of ethanol under 
an argon atmosphere. The sodium ethoxide was standardized 
with HCl solution using phenolhthalein as the indicator. 
Triphenylphosphine hydrobromide was prepared by passing 
hydrogen bromide into an ethanolic solution of 
40 
41 
triphenylphosphine. Tetrahydrofuran was dried over. sodium 
sulfate and distilled from the sodium ketyl of benzophenone 
under an argon atmosphere. 
Analyses 
Infrared spectra were run on a Perkin-Elmer model 681 
IR spectrophotometer using KBr pellets for solids and NaCl 
plates for liquid samples. Proton and C-13 NMR spectra 
were obtained on a Varian XL-300 spectrometer operated at 
300 MHz and 75.429 MHz respectively. Ultraviolet spectra 
were obtained on a Perkin-Elmer Lambda Array 3840 UV/VIS 
Spectrophotometer. Melting point data were performed on a 
MEL-TEMP melting point apparatus.and are uncorrected. Gas 
chromatographic analysis data were obtained on a 
Hewlett-Packard Model 5840A instrument with a 6 ft x 0.125 
in o.d. nickel column of 20% SE-30 on 80/100 mesh 
chromosorb Q and a thermal conductivity detector. Liquid 
chromtographic arialyses were accomplished on a Waters HPLC 
Model 590 equipped with Waters Differential Refractometer 
R401 and Beckman Model 153 Analytical UV detectors. 
Thin-layer chromtographic analysis was done using Eastman 
silica gel plates. Analytical samples were submitted to 
Galbraith Laboratories Inc., Knoxville, Tennessee, and 
Huffmann Laboratories Inc., Wheatridge, Colorado. 
General Procedures With Polymeric Reagents 
Polymeric samples were washed with chloroform, ether, 
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methylene chloride, methanol, water, and ethanol. All 
reactions were run in 3-neck flasks (round bottom) equipped 
with an overhead stirrer, argon or nitrogen inlet, reflux 
condenser, and serum stopper. Polymer samples were allowed 
to swell in a solvent for one hour with stirring prior to a 
reaction. 
19 Methyl 3-phenoxypropanoate (17) 
A solution of 3-phenoxypropanoic acid (_! __ ~_, 25.0 g, 
0.15 mole) and E-toluenesulfonic acid (0.008 mole) in 625 
mL of methanol was refluxed for 4 h under a nitrogen 
atmosphere. It was concentrated under vacuum, diluted with 
distilled water (125 mL), and brine (200 mL), and dried 
with anhydrous sodium sulfate. The solvent was removed 
under vacuum. Vacuum dis~illation of the resulting 
residual oil gave 23.95 g (88%) of 17 as a colorless 
liquid: bp 79-87°C/0.32 mm Hg (lit. 19 bp 85°C/0.4 mm Hg); 
-1 -1 0 IR (neat) 1750 cm (C=O), 1375 cm (CH 3 ); H-1 NMR 
2.72 (t, 2H, cg2co2cH 3 l, 3.64 (s, 3H, ocg3 l, 
4.16 {t, 2H, ocg2 J, 6.84-6.92 [m, 3H, Ar-H (ortho and 
para)], 7.20-7.25 [m, 2H, Ar-H (meta)]; C-13 NMR (CDC1 3 ) 
ppm 34.3 (~H 2co2 -), 51.7 (CH 3 ), 63.3 (OCH2 ), Ar-C 
[114.6 (ortho), 121.0 (para), 129.5 (meta), 158.5 (ipso)], 
171.4 (C=O). 
19 2-Methyl-4-phenoxy-2-butanol (18) 
A solution of methyl 3-phenoxypropanoate (l.1_, 15.37 g, 
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0.0853 mole) in dry ether (60 mL) was added dropwise under 
nitrogen to a stirred solution of methylmagnesium bromide 
in tetrahydrofuran (1.29 ~, 200 mL, 0.26 mole). The 
mixture was allowed to react for 4 h and was quenched with 
saturated ammonium chloride. The supernatant liquid was 
decanted and the residue was washed with dry ether (3 x 100 
mL). The combined organic solution was dried over sodium 
sulfate and the solvent was removed in vacuo. Vacuum 
distillation gave 12.31 g (80%) of~ as a colorless 
0 -1 liquid: bp 80-90 C/0.24 mm Hg; IR (neat) 3600-3200 cm 
(-OH); H-1 NMR (CDC1 3 ) o 1.30 [(s, 6H, (CH 3 J 2 ], 1.98 
(t., 2H, ArOCH2C!:!2 ), 2.57 (s, lH, -OH), 4.16 (t, 2H, 
Ar-oc~2 ), 6.88-6.98 [m, 3H, Ar-H- (ortho and para)], 
7.25-7.31 [m, 2H, Ar-H (meta)]; C-13 NMR (CDC1 3 ) ppm 29.4 
C(~H 3 J 2 , 41.5 (Ar~OCH2 cH2 ), 65.0 (Ar-OfH2cH2 ), 70.4 
[(CH3 J 2C-OH], Ar-C [114.5 (ortho), 121.0 (para), 
129.5 (meta), 158.5 (ipso)]. 
4 4 D. th 1 h (10. i 19 , - ime y c roman 
A solution of 2-methyl-4-phenoxy-2-butanol (~, 15.30 g, 
0.0849 mole) in nitromethane (100 mL) was added dropwise 
under nitrogen to a stirred suspension of anhydrous 
aluminum chloride (15.60 g, 0.012 mole) in nitromethane 
(100 mL). After stirring at room temperature for 6 h, a 
solution of 6 M HCl (160 mL) was added slowly. The layers 
were separated and the organic layer was washed with water 
(100 mL), saturated aqueous sodium bicarbonate (4 x 100 
mL). After drying with sodium sulfate, the solvent was 
removed in vacuo. Vacuum distillation gave 10.83 g (79%) 
of 19 as a colorless liquid: bp 45°C-56°C/0.16 mm Hg; 
IR (neat) 2960 cm- 1 , 2850 cm-l (C-H), 3080-3020 cm-l 
(C=CH); H-1 NMR (CDC1 3 ) 6 1.32 [s, 6H, (CH 3 ) 2 J, 1.80-
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1.84 [t, 2H, H(3)], 4.16-4.19 [t, .2H, H(2)], 6.77-7.27 (m, 
4H, Ar-H); C-13 NMR (CDC1 3 ) ppm 30.4 [(CH3 ) 2 ~J, 31.0 
[(~H 3 ) 2 CJ, 37.6 (-OCH2CH 2 ), 62.9 (-0£H 2CH2 ), 116.8 C(8), 
120.3 C(6), 126.8 C(5), 126.9 C(7), 131.5 C(5a), 153.4 C(8a). 
6-Ethanoyl-4,4-dimethylchroman (20) 19 
Anhydrous. aluminum chloride (3.40 g, 0.025 mole) in 22 
mL of nitromethane was added in . small portions to a 
solution of 4,4-dimethylchroman (11_, 4.00 g, 0.025 mole) 
and acetyl chloride (2.00 g, 0.025 mole) in nitromethane 
(35 mL) under nitrogen. After stirring at room temperature 
for 6 h, 6 ~ HCl (35 mL) was slowly added, and the 
resulting mixture was stirred for 10 minutes. The mixture 
was diluted with ether (40 mL) and the layers were 
separated. The organic layer was washed with water (40 
mL), saturated aqueous sodium bicarboante (4 x 30 mL), and 
brine (2 x 40 mL). After drying the solution over sodium 
sulfate, the solvent was removed under vacuum leaving a 
dark reddish brown oil. Vacuum distillation gave.2.42 g of 
20 (48%) as a yellowish liquid; bp 97°C-l00°C/0.035 
rrun Hg. A weighed amount of 20 (20 mg) was dissolved in 2 
mL of anhydrous ether and 5 microliters (50 micrograms) of 
this solution was injected onto a GC column. The results 
showed 2 peaks, retention time (relative area) 4.41 min 
(starting material 1.2_, 3%) and 7.24 min (product .?_Q, 
97%). IR (neat) 1680 cm-l (C=O); H-1 NMR 6 (CDC1 3 ) 
1.37 [s, 6H, (CH 3 )2 ], 1.83-1.87 [t, 2H, H(3)], 2.54 (s, 
3H, C~3 C=O), 4.23-4.27 [t, 2H, H(2)], 6.80-6.82 [d, lH, 
H(8~], 7.67-7.70 [dd, lH, H(7)], 7.95-7.96 [d, lH, H(5)]; 
C-13 NMR (CDC1 3 ) ppm 26.3 (CH 3 ), 30.6 [ (CH 3 ) 2£, 30.7 
[(~H 3 ) 2C], 37.0 (OCH 2rH 2 ), 63.4 (O~H2CH 2 ), 116.9 
[C(8)], Ar-C (127.8, 128.2, 130.0, 131.6), 158.0 [C(8a)], 
196.8 (C=O). 
[(Triphenylphosphonium)-l-methyl-l-
propenyl-4,4-dimethylchroman-4,4-
dirnethylchroman Bromide] (22) 
A solution of the acetylchroman (~, 5.45 g, 26.67 
mmole) in dry ether (20 mL) was added dropwise under 
nitrogen to a stirred solution of vinyl magnesium bromide 
(1.0 ~, 40 mL, 40 rnmole) in tetrahydro~uran. The mixture 
was allowed to react for 3.5 h and was quenched with 
saturated ammonium chloride. The supernatant liquid was 
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decanted and the residue was washed with dry ether (3 x 100 
mL). The combined organic solution was dried over sodium 
sulfate and the solvent was removed in vacuo to give 7.07 g 
of 21. The product~ was used in the next step 
without purification. A solution of 21 (7.07 g, 30.47 
rnmole) in methanol (30 mL) was added to a cold solution of 
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triphenylphosphine hydrobromide (10.45 g, 30.47 mmole) in 
methanol (30 mL). The mixture was'kept at room temperature 
for 2.5 hand poured slowly into ether (550 mL). The preci-
pitated salt was filtered off and dried for 2 h under 
vacuum at room temperature to yield 9.14 g of~, corres-
ponding to a 61.5% yield. mp 246-249°C(dec); IR(KBr) 
1667 cm-l (C=C), 2975 cm-l (C-H); H-1 NMR (CDC1 3 ) o 
1.29 [s, 6H, (CH 3 J2 , 1.62 [s, 3H, CH 3 (10)], 
1.76-1.84 [t, 2H, H(3)], 4.14-4.20 [t, 2H, H(2)], 4.75-4.83 
[dd, 2H, H(l2)], 5.54 [m, lH, H(ll)], 6.68-6.71 [d, lH, 
H(8).], 6.88-6.91 [d, lH, H(7)], 7.07 [s, lH, H(5)], 7.60-
8.00 [m, 15H, (Ph) 3 ]. 
Oxa-retinoic Acid (15) 
A solution of ~-butyllithium in hexane (8.20 mL, 
1. 31 !:!' 10. 77 mmo.le) was added dropwise under argon to a 
stirred suspension of the phsophonium salt (~, 5.99 g, 
10.77 mmole) in dry ether (100 mL). The resulting dark 
reddish brown mixture was stirred at room temperature for 
ten minutes. A solution of the ethyl 3-formyl-2-butenoate 
(~, 1.55 g, 10.77 mmole) (Hoffmann-La Roche) in dry 
ether (30 mL) was added. After stirring at room tempera-
ture for 22 h, the mixture was filtered. The resulting 
solid was washed with ether (250 mL) and the combined 
filtrates were concentrated in vacuo to afford 2.40 g of 
crude 24 (68%). The ethyl oxa-retinoid ester (~) was 
chromatographed on a silica gel (40 µm, J.T. Baker Co.) 
and eluted with 2% ethyl acetate:98% petroleum ether to 
afford 24 as the middle fraction. Hydrolysis of 70 mg 
of the oxa-retinoid ester (24) was then effected with a 
potassium hydroxide solution (1.20 g KOH in 2.00 mL of 
water) and absolute ethanol (8 mL). The mixture was 
protected from light and stirred at 5o 0 c for 4 h under 
nitrogen. The solution was cooled to o0 c, acidified with 
6 M HCl and extracted with chloroform. The chloroform 
extracts were washed with brine, dried (MgS04 )~ and 
evaporated. The resulting crystals of 15 were 
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recrystallized from absolute ethanol to give 29 mg (45%) of 
0 -1 ]: __ ~_,mp 191.5-192.5 C; IR(KBr) 3250-2500 cm (OH), 
-1 1680 cm (C=O); H-1 NMR (CDC1 3-DMSO-d6 ) 1.35 [s, 6H, 
(C!!3 ) 2 , 1.79-1.83 [t, 2H, H(3)], 2.20 [s, 3H, CH3 
(10 or 15)], 2.32 [s, 3H, CH 3 (10 or 15)], 4.15-4.18 [t, 
2H, H(2)], 5. 76 [s~ lH, R-C(CH3 )=C~C02 H], 6.40-6.45 
[d, lH, J= 11 Hz, H(ll)], 6.53-6.57 [d, lH, J= 15 Hz, 
H(l3)], 6.68-6.71 [d, lH, J= 9 Hz, H(8)], 6.96-7.05 [dd, 
lH, J= 11, 15 Hz, H(l2)], 7.19-7.23 [dd, lH, J= 2, 9 Hz, 
H(7)], 7.41-7.42 [d, lH, J= 2 Hz, H(5)]; C-13 NMR (CDC1 3 
-DMSO-d6 ) 13.4 [C(l5)], 16.0 [C(lO)], 30.4 [C(4}], 30.8 
[f_H 3 ] 2 ], 37.2 [C(3)], 62.6 [C(2)], 116.5 [C(8 or 
16)], 119.2 [C(8 or 16)], 123.9 [C(5, 7, or 11)], 124.3 
[C(5, 7, or 11)], 124.6 [C(5, 7, or 11)], 130.9 [C(l2)], 
131.1 [C(6 or 9)], 134.0 [C(6 or 9)], 135.1 [C(l3)], 139.1 
[C(4a)], 151.5 [C(8a or 14)], 153.2 [C(8a or 14)], 168.0 
[C(l7)]; UV (absolute ethanol);\ = 341.8 nm, E= 26000; 
max 
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Thin layer chromatography, plate: Eastman 13181 silica gel, 
solvent: petroleum ether:ethanol:acetone (2:1:1), only one 
spot was observed, Rf 0.50; Anal.: Calcd. for c20 H24o3 , C, 
76.89; H, 7.74. Found: C, 76.79; H 7.90. 
Oxa-retinoid Ester (24) ~ 
Sodium Ethoxide Method 
A solution of sodium ethoxide in ethanol (21.10 mL, 
0.51 ~, 10.77 mmole) was added dropwise under nitrogen to 
a stirred suspension of the phosphonium salt (±1_, 5.99 g, 
10.77 mmole) in methylene chloride (60 mL). The resulting 
mixture was stirred at room temperature for ten minutes. A 
solution of the ethyl 3-formyl-2-butenoate (l}, 1.55 g, 
10.77 mmole) (Hoffmann-La Roche) in methylene chloride (30 
mL) was added slowly. After stirring at room temperature 
for 2 h, the mixture was diluted with hexane:ethyl acetate 
(7:3) (600 mL) and filtered. The filtrates were 
concentrated in vacuo to obtain 3.27 g of crude 24 (89%). 
The crude retinoid ester (l_!) was hydrolyzed to the oxa-
retinoic acid (15) as described earlier. 
Methyl-l-propenyl-4,4-dimethylchroman-
polystyrylphosphonium Bromide (29) 
Polystyryldiphenylphosphonium bromide (~, 7.69 g, 
5.71 meq Br) was added to a crude solution of l-methyl-l-
propenyl-4,4-dimethylchroman (~, 2.13 g, 9.17 mmole) in 
dimethylformamide (40.0 mL). The mixture was stirred under 
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nitrogen at 50 °c for 24 h and then at room temperature 
for 24 h. The polymer was filtered and washed with toluene 
(40 mL), methylene chloride (40 mL), and diethyl ether (3 x 
40 mL). The sample was dried at 50 °c under vacuum for 
20 h to give 7.91 g of 29 (21%). Anal. Found: P 3.64% 
(1.18 meq P/g polymer); Br 5.93% (0.74 meq Br/g polymer). 
Wittig Reaction Using Polymer Support 
n-Butyllithium Method 
Anhydrous diethyl ether (SO mL) was added to the 
previously prepared ~ (3.83 g, 1.00 mmole) under a 
nitrogen atmosphere. Using an addition funnel, g-butyl-
lithium (3.00 mL, 1.60 ~' 4.80 mmole) was slowly added. 
Upon addition of the g-butyllithium, the red-colored 
solution was stirred for another 10 min. A solution of 
ethyl 3-formyl-2-butenoate (~, 0.67 g, 4.72 mmole) in 
ether (10 mL) was slowly added. After stirring for an 
additional·24 h, the mixture was filtered. The solid that 
had accumulated on the funnel was washed with diethyl ether 
(150 mL) and the combined filtrates concentrated. Pentane 
(10 mL) was added to the concentrate and the solution was 
filtered in a filter unit (Millex-HV, 0.45 µm). The sol-
vent was evaporated by means of a vacuum rotavapor to give 
219.2 mg of 24 (65%). 
Wittig Reaction Using Polymer Support 
Sodium Ethoxide Method 
Anhydrous diethyl ether (SO mL) was added to the 
previously prepared~ (3.86 g, 1.00 mrnole) under 
nitrogen atmosphere. Sodium ethoxide (10.0 mL, 0.48 ~' 
4.83 mrnole) was slowly added using an addition funnel. 
Upon addition of the sodium ethoxide, the solution was 
stirred for an additional 10 min. A solution of ethyl 
3-formyl-2-butenoate (£1., 0.67 g, 4.72 mrnole) in ether 
was slowly added. After stirring for an additional 24 h, 
the mixture was filtered. The solid polymer was washe~ 
with diethyl ether and the combined filtrates were 
concentrated. The product 24 was redissolved in pentane 
and refiltered in a filter unit (Millex-HV, 0.45 µm) with 
the use of a disposable syringe. The solvent was 
evaporated to give 288.4 mg of~ (85%). 
Procedure for Reversed Phase High Per-
formance Liquid Chromatography 
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About 50 mg of crude oxa-retinoid ester (24) was dis-
solved in 4.0 mL of either methanol or acetonitrile. The 
mixture was transferred to a vial with an appropriate 
cover. The mixture was shaken for 60 s and filtered 
through a filter unit (Millex-HV, 0.45 µm filter, Millipore 
Corporation, West Germany). During injections, a 20 µL 
syringe (Hamilton Company, Reno, Nevada) was used. The 
solutions were kept cold and the fractions collected were 
kept in a covered black container filled with ice. Solvent 
systems used were filtered in a millipore filter (0.45 µm 
filter, Millipore Corporation) with the aid of a 
filtration kit (Millipore Corporation, Bedford, 
Massachusetts). The following parameters were used: 
Column: Whatman Partisil 5-0DS-3; mobile phase, 
methanol:0.01 M ammonium acetate (90:10); flow rate, 1.00 
mL/min; injection loop, 20 µL; injection volume, 20 µL; 
attenuation, 64x or NL 128x; detection, refractive index. 
Procedure for Normal Phase High Per-
formance Liquid Chromatography 
The fractions were dissolved in HPLC grade hexane. 
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The same procedure as above was followed. The following 
parameters were used. Column: Whatman Partisil 5 Silica; 
mobile phase; hexane:diethyl ether (90:10); flow rate, 1.00 
mL/min; injection loop, 20 µL; injection volume, 20 µL; 
attenuation, 1.28; pressure, 400-600 psi; detection, ultra-
violet absorption at 313 nm. 
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